Results from the pivotal phase (Ph) 2b HERIZON-BTC-01 study: Zanidatamab in previously-treated HER2-amplified biliary tract cancer (BTC) Meeting Abstract

International Collaboration

cited authors

  • Pant, Shubham; Fan, Jia; Oh, Do-Youn; Choi, Hye Jin; Kim, Jin Won; Chang, Heung-Moon; Bao, Lequn; Sun, Hui-Chuan; Mercade, Teresa Macarulla; Xie, Feng; Metges, Jean Philippe; Jieer, Ying; Bridgewater, John A.; Tejani, Mohamedtaki Abdulaziz; Chen, Emerson Yu-Sheng; Wasan, Harpreet Singh; Ducreux, Michel Pierre; Ma, Jia-Fang; Garfin, Phillip M.; Harding, James J.

Publication Date

  • June 1, 2023

webpage

published in

category

volume

  • 41

issue

  • 16